The gut as a regulator of early inflammation in type 1 diabetes

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 18, Issue 4, 2011, Pages 241-247

  Vaarala, Outi ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

beta cell autoimmunity; enteral infections; gut microbiota; intestinal permeability

Indexed keywords

CHEMOKINE RECEPTOR CCR6; CLAUDIN 1; GLUTAMATE DECARBOXYLASE 65; HLA ANTIGEN CLASS 2; INSULIN; INTERLEUKIN 10; INTERLEUKIN 17; JUNCTIONAL ADHESION MOLECULE A; OCCLUDIN; PROTEIN VP7; PROTEIN ZO1; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANTIBODY RESPONSE; ARTIFICIAL MILK; BACTERIAL VIRULENCE; BINDING AFFINITY; BIOBREEDING RAT; CELIAC DISEASE; DIET THERAPY; DISEASE ASSOCIATION; ENTERITIS; ENTEROVIRUS INFECTION; FECES MICROFLORA; FOLLOW UP; GENETIC RISK; HUMAN; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS JOHNSONII; LACTOBACILLUS REUTERI; MUCOSAL IMMUNITY; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; REVIEW; ROTAVIRUS INFECTION; TH17 CELL;

ANIMALS; AUTOIMMUNITY; CASEINS; DIABETES MELLITUS, TYPE 1; HUMANS; INFLAMMATION; INSULIN-SECRETING CELLS; INTESTINES;

EID: 79960777798     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e3283488218     Document Type: Review

References (50)

1. Vaarala O, Atkinson MA, Neu J. The 'perfect storm' for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 2008; 57:2555-2562.
2. Turley SJ, Lee JW, Dutton-Swain N, et al. Endocrine self and gut nonself intersect in the pancreatic lymph nodes. Proc Natl Acad Sci U S A 2005; 102:17729-17733. (Pubitemid 41803565)
3. Hänninen A, Nurmela R, Maksimow M, et al. Islet beta-cell-specific Tcells can use different homing mechanisms to infiltrate and destroy pancreatic islets. Am J Pathol 2007; 170:240-250. (Pubitemid 47339203)
4. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009; 9:799-809.
5. Graham S, Courtois P, Malaisse WJ, et al. Enteropathy precedes type 1 diabetes in the BB rat. Gut 2004; 53:1437-1444. (Pubitemid 39265262)
6. Watts T, Berti I, Sapone A, et al. Role of the intestinal tightjunction modulator zonulin in the pathogenesis oftype I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci U S A 2005; 102:2916-2921. (Pubitemid 40299891)
7. Neu J, Reverte CM, Mackey AD, et al. Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes. J Pediatr Gastroenterol Nutr 2005; 40:589-595. (Pubitemid 40617187)
8. Visser JT, Lammers K, Hoogendijk A, et al. Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone biobreeding rat Diabetologia 2010; 53:2621-2628.
9. Lee AS, Gibson DL, Zhang Y, et al. Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia 2010; 53:741-748.
10. Luopajärvi K, Savilahti E, Virtanen SM, et al. Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in child-hood. Pediatr Diabetes 2008; 9:434-441.
11. Vaarala O. Leaking gut in type 1 diabetes. Curr Opin Gastroenterol 2008; 24:701-706.
12. Bosi E, Molteni L, Radaelli MG, et al. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia 2006; 49:2824-2827. (Pubitemid 44730283)
13. Westerholm-Ormio M, Vaarala O, Pihkala P, et al. Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes. Diabetes 2003; 52:2287-2295. (Pubitemid 37059499)
14. Auricchio R, Paparo F, Maglio M, et al. In vitro-deranged intestinal immune response to gliadin in type 1 diabetes. Diabetes 2004; 53:1680-1683. (Pubitemid 38857024)
15. Tiittanen M, Westerholm-Ormio M, Verkasalo M, et al. Infiltration of forkhead box P3-expressing cells insmall intestinal mucosain coeliacdisease butnot in type 1 diabetes. Clin Exp Immunol 2008; 152:498-507. (Pubitemid 351661513)
16. Karczewski J, Troost FJ, Konings I, et al. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 2010; 298: G851-G859.
17. Coombes JL, Powrie F. Dendriticcellsin intestinal immune regulation. Nat Rev Immunol 2008; 8:435-446.
18. Sudo N, Sawamura S, Tanaka K, et al. The requirement of intestinal bacterial flora for the development of an Ig E production system fully susceptible to oral toleranceinduction.JImmunol 1997; 159:1739-1745. (Pubitemid 127484159)
19. Tsuda M, Hosono A, Yanagibashi T, et al. Intestinal commensal bacteria promote T cell hyporesponsiveness and down-regulate the serum antibody responses induced by dietary antigen. Immunol Lett 2010; 132:45-52.
20. Brugman S, Klatter FA, Visser JT, et al. Antibiotic treatment partially protects against type 1 diabetes in the bio-breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 2006; 49:2105-2108. (Pubitemid 44168478)
21. Roesch LF, Lorca GL, Casella G, et al. Culture-independent identification of gutbacteriacorrelated withtheonsetof diabetesin arat model. ISMEJ 2009; 3:536-548.
22. Alam C, Valkonen S, Palagani V, et al. Inflammatory tendencies and over-production of IL-17 in the colon of young NOD mice are counteracted with diet change. Diabetes 2010; 59:2237-2246.
23. Wen L, Ley RE,Volchkov PY, et al. Innate immunityand intestinal microbiota in the development of Type 1 diabetes. Nature 2008; 455:1109-1113.
24. Valladares R, Sankar D, Li N, et al. Lactobacillus johnsonii N6.2 mitigates the development oftype 1 diabetes in BB-DP rats. PLo S One 2010; 5:e10507.
25. Lau K, Benitez P,Ardissone A, et al. Inhibition oftype 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J Immunol 2011; 186:3538-3546.
26. Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010; 129:311-321.
27. Honkanen J, Nieminen JK, Gao R, et al. IL-17 immunity in human type 1 diabetes. J Immunol 2010; 185:1959-1967.
28. Emamaullee JA, Davis J, Merani S, et al. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009; 58: 1302-1311.
29. Bending D, De La Peña H, Veldhoen M, et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 2009; 119:565-572.
30. Marwaha AK, Crome SQ, Panagiotopoulos C, et al. Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes. J Immunol 2010; 185:3814-3818.
31. Giongo A, Gano KA, Crabb DB, et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J 2011; 5:82-91.
32. Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 2011; 342:d35. doi: 10.1136/bmj.d35.
33. Honeyman MC, Stone NL, Falk BA, et al. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens. J Immunol 2010; 184:2204-2210.
34. Ylipaasto P, Kutlu B, Rasilainen S, et al.Global profiling ofcoxsackievirus-and cytokine-induced gene expression in human pancreatic islets. Diabetologia 2005; 48:1510-1522. (Pubitemid 41175504)
35. Oikarinen M,Tauriainen S, Honkanen T, et al. Detection ofenteroviruses in the intestine of type 1 diabetic patients. Clin Exp Immunol 2008; 151:71-75. (Pubitemid 350230982)
36. Oikarinen S, Martiskainen M, Tauriainen S, et al. Enterovirus RNA in blood is linked to the development oftype 1 diabetes. Diabetes 2011; 60:276-279.
37. Stene LC, Oikarinen S, Hyöty H, et al. Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 2010; 59:3174-3180.
38. Tapia G, Cinek O, Rasmussen T, et al. Human enterovirus RNA in monthly fecal samples and islet autoimmunity in Norwegian children with high genetic riskfortype 1 diabetes: the MIDIA study. Diabetes Care 2011;34:151-155.
39. Graham KL, Sanders N, Tan Y, et al. Rotavirus infection accelerates type 1 diabetes in mice with established insulitis. J Virol 2008; 82:6139-6149. (Pubitemid 351875096)
40. Vaarala O. Is it dietary insulin? Ann N Y Acad Sci 2006; 1079:350-359. (Pubitemid 44968746)
41. Knip M, Virtanen SM, Seppä K, et al. Finnish TRIGR Study Group Dietary intervention in infancy and later signs of beta-cell autoimmunity. N Engl J Med 2010; 363:1900-1908.
42. Vaarala O, Knip M, Ilonen J, et al. Removal of bovine insulin from cow's milk formula protects from early initiation of beta-cell autoimmunity. Diabetes 2010; 59 (Suppl 1):A88.
43. Norris JM, Barriga K, Klingensmith G, et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 2003; 290:1713-1720. (Pubitemid 37430621)
44. Ziegler A-G, Schmid S, Huber D, et al. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 2003; 290: 1721-1728. (Pubitemid 37430622)
45. Mojibian M, Chakir H, Lefebvre DE, et al. Diabetes-specific HLA-DR-restricted proinflammatory T-cell response to wheat polypeptides in tissue transgluta-minase antibody-negative patients with type 1 diabetes. Diabetes 2009; 58:1789-1796.
46. Chakir H, Lefebvre DE, Wang H, et al. Wheat protein-induced proinflamma-tory T helper 1 bias in mesenteric lymph nodes ofyoung diabetes-prone rats. Diabetologia 2005; 48:1576-1584. (Pubitemid 41175511)
47. Maurano F, Mazzarella G, Luongo D, et al. Small intestinal enteropathy in nonobese diabetic mice fed a diet containing wheat. Diabetologia 2005; 48:931-937. (Pubitemid 40767987)
48. Funda DP, Kaas A, Tlaskalová-Hogenová H, Buschard K. Gluten-free but also gluten-enriched (gluten+) diet prevent diabetes in NOD mice; the gluten enigma in type 1 diabetes. Diabetes Metab Res Rev 2008; 24:59-63. (Pubitemid 351176001)
49. Lammers KM, Lu R, Brownley J, Lu B, et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 2008; 135:194-204.
50. Hansen AK, Ling F, Kaas A, et al. Diabetes preventive gluten-free diet decreases the number of caecal bacteria in nonobese diabetic mice. Diabetes Metab Res Rev 2006; 22:220-225. (Pubitemid 43805403)